News NHS under fire for rationing hep C drugs NHS England tried to interfere with NICE appraisals, says BMJ.
News Gilead cancer drug can stay on EU market Safety experts recommend antibiotics after Zydelig treatment.
US Gilead hopes cut-price pan-genomic hep C combo will revive s... Epclusa is first treatment for all six major virus genotypes.
Articles Pharma news round-up: Pfizer-Allergan merger scrapped, Gilea... A round-up of this week's top pharma and healthcare news – plus reaction from social media. Marco Ricci reports.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
